When dopamine is released from the substantia nigra, it inhibits the striatum, causing it to release less inhibitory neurotransmitters.
However, trans-cinnamaldehyde showed clearly less inhibitory activity towards lactobacilli than carvacrol and thymol.
Damage from HD causes the striatum to release a weaker chemical signal, resulting in less inhibitory neurotransmitters, less inhibition of the motor cortex, and more movement.
In this case, the striatum still releases less inhibitory neurotransmitters, but in the direct pathway this action leads to more inhibition of the motor cortex and less movement.
Additionally, Citrate showed slower and less inhibitory effects on long-term hMSC cell proliferation compared with 1,8-Octanediol.
Furthermore, osteogenic differentiation of hMSCs exposure to Citrate resulted in less inhibitory effect on alkaline phosphatase (ALP) production.
Ascorbyl palmitate had less inhibitory effect than erythorbic acid and a combination of the two provided no further protection.
Considering these structures do not extend and amplify during PCR they are less inhibitory to target amplification, as they do not cause a reduction in available PCR reagents and the primer sequence remains unaltered.
Dopamine that goes to D1 receptors causes the striatum to release less inhibitory neurotransmitters, which ripples through the whole direct pathway and ultimately leads to inhibition of the motor cortex (preventing movement).
Dopamine that goes to D2 receptors also causes the striatum to release less inhibitory neurotransmitters, but because of a different pathway progression, ultimately leads to less inhibition of the motor cortex (causing movement).
Their monofunctionalized analog and ortho-, meta- or para-heterofunctionalized morpholine-containing complexes with the single carboxyphenylsulfide substituent showed a substantially less inhibitory activity.
